Zobrazeno 1 - 10
of 184
pro vyhledávání: '"van Bodegraven, A. A."'
Autor:
Gerard Dijkstra, Andrea E. van der Meulen-de Jong, Herma H. Fidder, M. W. M. D. Lutgens, Lennard P L Gilissen, Nofel Mahmmod, J Schultheiss, Shaden Mahmmod, Frank Hoentjen, Adriaan C I T L Tan, Lisa J T Smits, Bas Oldenburg, Ad A. van Bodegraven
Publikováno v:
Inflammatory Bowel Diseases, 27(12), 1954-1962. OXFORD UNIV PRESS INC
Inflammatory Bowel Diseases, 27, 1954-1962
Inflammatory Bowel Diseases, 27(12), 1954-1962. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 27, 12, pp. 1954-1962
Inflammatory Bowel Diseases, 27, 1954-1962
Inflammatory Bowel Diseases, 27(12), 1954-1962. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 27, 12, pp. 1954-1962
Background Patients suffering from inflammatory bowel diseases (IBD) and treated with originator infliximab are increasingly being switched to biosimilars. Some patients, however, are “reverse switched” to treatment with the originator. Here we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b46bb5e73e3a6fedc98560df43246e
http://hdl.handle.net/1887/3276514
http://hdl.handle.net/1887/3276514
Publikováno v:
Osteoporosis International
van Bodegraven, A A & Bravenboer, N 2020, ' Perspective on skeletal health in inflammatory bowel disease ', Osteoporosis International, vol. 31, no. 4, pp. 637-646 . https://doi.org/10.1007/s00198-019-05234-w
Osteoporosis International, 31(4), 637-646. SPRINGER LONDON LTD
van Bodegraven, A A & Bravenboer, N 2020, ' Perspective on skeletal health in inflammatory bowel disease ', Osteoporosis International, vol. 31, no. 4, pp. 637-646 . https://doi.org/10.1007/s00198-019-05234-w
Osteoporosis International, 31(4), 637-646. SPRINGER LONDON LTD
Osteopenia and osteoporosis are common features in inflammatory bowel disease (IBD), comprising both Crohn's disease and ulcerative colitis. Moreover, Crohn's disease is associated with increased fracture risk. The etiology of bone loss in IBD is mul
Autor:
Marie J. Pierik, Tamara Munnecom, Paul J. Boekema, Daisy Jonkers, Mariëlle Romberg-Camps, Ad A. van Bodegraven, Laura Janssen, Manuela A. Joore, Michèl Aquarius, Lloyd Brandts, Jeoffrey J L Haans, Adrian A. M. Masclee
Publikováno v:
BMJ Open, 11(5):042885. BMJ Publishing Group
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
IntroductionCrohn’s disease (CD) is a chronic inflammatory bowel disease with a heterogeneous clinical presentation, relapse rate and treatment response. At present, no markers are available to adequately predict disease course at diagnosis. To pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082cad4540ff81c812c4b0ebca66caee
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
Autor:
Birgit I. Lissenberg-Witte, Joanne Verheij, Bindia Jharap, Maurice G. Russel, Elisabeth Bloemena, Dirk P. van Asseldonk, Gijsbert den Hartog, Nanne K. H. de Boer, Melek Simsek, Dik B. Westerveld, Carin M.J. van Nieuwkerk, Adriaan A. van Bodegraven, Marco C. Becx, Chris J. J. Mulder
Publikováno v:
Scandinavian Journal of Gastroenterology, 54(6), 753-760. Informa Healthcare
van Asseldonk, D P, Simsek, M, de Boer, N K H, Jharap, B, Bloemena, E, den Hartog, G, Westerveld, D B, Becx, M C, Russel, M G, Lissenberg-Witte, B I, van Nieuwkerk, C M, Mulder, C J J, Verheij, J & van Bodegraven, A A 2019, ' Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients ', Scandinavian Journal of Gastroenterology, vol. 54, no. 6, pp. 753-760 . https://doi.org/10.1080/00365521.2019.1629006
Scandinavian journal of gastroenterology, 54(6), 753-760. Informa Healthcare
van Asseldonk, D P, Simsek, M, de Boer, N K H, Jharap, B, Bloemena, E, den Hartog, G, Westerveld, D B, Becx, M C, Russel, M G, Lissenberg-Witte, B I, van Nieuwkerk, C M, Mulder, C J J, Verheij, J & van Bodegraven, A A 2019, ' Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients ', Scandinavian Journal of Gastroenterology, vol. 54, no. 6, pp. 753-760 . https://doi.org/10.1080/00365521.2019.1629006
Scandinavian journal of gastroenterology, 54(6), 753-760. Informa Healthcare
Background: Thioguanine is associated with liver toxicity, especially nodular regenerative hyperplasia (NRH). We assessed if liver histology alters during long-term maintenance treatment with thioguanine in patients with inflammatory bowel disease (I
Autor:
Bjorn Winkens, Jeoffrey J L Haans, Andrea E. van der Meulen-de Jong, Daisy Jonkers, Ad A.M. Masclee, Nofel Mahmmod, Dion S J Wintjens, Marco C. Becx, Tineke Markus, Ad A. van Bodegraven, Marie J. Pierik, Mariëlle Romberg-Camps, Marin J de Jong, Jeroen Maljaars
Publikováno v:
Journal of Crohn's & Colitis, 13(4), 410-416. Oxford University Press
Journal of Crohn's and Colitis, 13(4), 410-416
Journal of Crohn's and Colitis, 13(4), 410-416
Background and Aims Inflammatory bowel disease [IBD] is characterized by recurrent disease flares. The impact of psychosocial wellbeing on the occurrence of flares is unclear. In this prospective study, we aimed to evaluate the association between pa
Autor:
Melek Simsek, Rupa Banerjee, Javier P. Gisbert, Adriaan A. van Bodegraven, Rupert W. Leong, Azhar Ansari, Graham L. Radford-Smith, Vineet Ahuja, Margien L. Seinen, Richard B. Gearry, Timothy H. Florin, David P. Epstein, Nanne K. H. de Boer, Jean-Frederic Colombel, Sven Almer, Chris J. J. Mulder, Jake Begun, Murray L. Barclay, Miles P. Sparrow, Markus F. Neurath
Publikováno v:
de Boer, N K H, Thiopurine Working Group, Ahuja, V, Almer, S, Ansari, A, Banerjee, R, Barclay, M L, Begun, J, van Bodegraven, A A, Colombel, J-F, Epstein, D P, Florin, T H J, Gearry, R B, Gisbert, J P, Leong, R W, Mulder, C J J, Neurath, M F, Radford-Smith, G L, Seinen, M L, Simsek, M & Sparrow, M P 2019, ' Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones ', Gastroenterology, vol. 156, no. 1, pp. 11-14 . https://doi.org/10.1053/j.gastro.2018.11.039
Gastroenterology, 156(1), 11-14. W.B. Saunders Ltd
Gastroenterology, 156(1), 11-14. W.B. Saunders Ltd
Autor:
J. Jorissen, F. Tan, Peter J.M. Weijs, Nicolette J. Wierdsma, D. Krebbers, Maarten R. Soeters, M. H. Joosten, A. van Bodegraven, L. Konings, Hinke Kruizenga, L. van Aken
Publikováno v:
Clinical Nutrition Espen
Autor:
Ashkan Rezazadeh Ardabili, Rob H. Creemers, Daisy Jonkers, Marie J. Pierik, Mariëlle Romberg-Camps, Ad A. van Bodegraven, Mathie P. G. Leers
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0258271 (2021)
PLOS ONE, 16(10):e0258271. Public Library of Science
PLoS ONE, Vol 16, Iss 10, p e0258271 (2021)
PLOS ONE, 16(10):e0258271. Public Library of Science
Objective Data on the course of severe COVID-19 in inflammatory bowel disease (IBD) patients remains limited. We aimed to determine the incidence rate and clinical course of severe COVID-19 in the heavily affected South-Limburg region in the Netherla
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
Autor:
Lauranne A A P Derikx, Lennard P L Gilissen, Moniek H P Gorter, Adriaan C.I.T.L. Tan, Tessa E H Römkens, Marten A Lantinga, Eric R C Halet, Rachel L. West, Jeroen M. Jansen, Rob H. Creemers, Carmen S. Horjus, Meike M C Hirdes, Dirk J. de Jong, Bindia Jharap, Adriaan A. van Bodegraven, Nofel Mahmmod, M. W. M. D. Lutgens, Alexander Bodelier, Ludger S M Epping Stippel, Frank Hoentjen, Sjoukje Nauta, Maarten A van Dijk, Willemijn A van Dop, Paul J. Boekema, Maurice G. Russel
Publikováno v:
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 15, 529-539
Journal of Crohn's and Colitis, 15, 4, pp. 529-539
Journal of Crohns and Colitis
Journal of Crohn's and Colitis, 15, 529-539
Journal of Crohn's and Colitis, 15, 4, pp. 529-539
Journal of Crohns and Colitis
Background and Aims The COVID-19 risk and disease course in inflammatory bowel disease [IBD] patients remains uncertain. Therefore, we aimed to assess the clinical presentation, disease course, and outcomes of COVID-19 in IBD patients. Second, we det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23126db91e69b27ddeeac9dbfac1b073
https://doi.org/10.1093/ecco-jcc/jjaa215
https://doi.org/10.1093/ecco-jcc/jjaa215
Autor:
Lennard P L Gilissen, Alette Daniels, Dennis R Wong, Marielle Romberg, Arnold Stronkhorst, Ad A. van Bodegraven, Rudaba Tajzai, Marieke Pierik, Karin Steenhuisen
Publikováno v:
European Journal of Gastroenterology & Hepatology, 33(1S Suppl 1), e102-e107. LIPPINCOTT WILLIAMS & WILKINS
Gilissen, L P L, Tajzai, R, Romberg, M, Pierik, M, Stronkhorst, A, Steenhuisen, K, van Bodegraven, A, Daniels, A & Wong, D 2021, ' The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients ', European journal of gastroenterology & hepatology, vol. 33, no. 1S Suppl 1, pp. e102-e107 . https://doi.org/10.1097/MEG.0000000000001980
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e102-e107. Lippincott Williams and Wilkins
Gilissen, L P L, Tajzai, R, Romberg, M, Pierik, M, Stronkhorst, A, Steenhuisen, K, van Bodegraven, A, Daniels, A & Wong, D 2021, ' The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients ', European journal of gastroenterology & hepatology, vol. 33, no. 1S Suppl 1, pp. e102-e107 . https://doi.org/10.1097/MEG.0000000000001980
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e102-e107. Lippincott Williams and Wilkins
INTRODUCTION: Nodular regenerative hyperplasia (NRH) has been associated with thiopurine therapy in patients with inflammatory bowel disease (IBD), but prevalence and prognosis of NRH remain unclear. This study is a cross-sectional search for NRH in